Atorvastatin in Combination With Narrowband UV-B in Adult Patients With Active Vitiligo: A Randomized Clinical Trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 29617528.
- Also identified by DOI 10.1001/jamadermatol.2017.6401 and PMC identifier 6583848.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This randomized clinical trial evaluates the use of atorvastatin combined with narrowband UV-B therapy vs narrowband UV-B therapy alone in adult patients with active vitiligo.
Medical subject headings
- Atorvastatin
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Ultraviolet Therapy
- Vitiligo